20 drug(s) with this reaction
16,837 total reports
Pyrexia has been reported as an adverse reaction across 20 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 16,837 adverse event reports mention pyrexia in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with pyrexia, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have pyrexia listed in their FDA adverse event reports, sorted by report count:
In addition to pyrexia, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
20 drug(s) manufactured by Haleon Us Holdings Llc have pyrexia listed in their FDA adverse event reports: DICLOFENAC SODIUM, CALCIUM CARBONATE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, IBUPROFEN SODIUM, and others.
There are a combined 16,837 reports of pyrexia across 20 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.